EHA 2025

June 12-15, 2025
Milan, Italy

European Hematology Association Hybrid Congress 2025

Explore more Hematology congress materials

Results(3)

Hematology

Defibrotide Treatment Outcomes in Patients With Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Occurring After Exposure to Inotuzumab Ozogamicin or Gemtuzumab Ozogamicin

Author(s): Mohamad Mohty, Franco Locatelli, Régis Peffault de Latour et al.

Long-Term Real-World Experience With CPX-351 Treatment for Acute Myeloid Leukemia in England

Author(s): Alexandrina Lambova, Eleanor Ralphs, Karabo Keapoletswe et al.

Evolution of Real-World Treatment Pathways for Secondary Acute Myeloid Leukemia in England

Author(s): Alexandrina Lambova, Eleanor Ralphs, Karabo Keapoletswe et al.

Disclaimer

This AI model is continuing to learn and its responses are based on learned data patterns. It should not replace professional judgment. Please verify the information before use, and feedback is welcome to improve its accuracy.

Please do not include personal or confidential information in your searches. For information on how to report an adverse event or product complaint for a Jazz product, please visit: https://www.jazzpharma.com/medicines/drug-safety/.